High levels of heme or iron are toxic to many bacteria, including
C. diphtheriae, and the expression of genetic systems involved in the uptake and utilization of iron or iron-containing compounds such as heme is often tightly regulated in bacteria (
7,
9). Iron and hemin transport systems in
C. diphtheriae are regulated by the DtxR repressor in an iron-dependent manner (
18,
19). While high iron levels repress the expression of numerous genes in
C. diphtheriae, the presence of extracellular hemin or heme sources like hemoglobin results in both activation and repression of gene expression, which are mediated by the ChrAS and HrrAS two-component systems (
4,
5,
18). In this study, we have identified in
C. diphtheriae an ABC transport system, HrtAB, that is required for resistance to the toxic effects of high levels of hemin and whose genes are regulated by the ChrAS two-component system in a heme-dependent manner. The recent report that identified the
hrtAB genes in
S. aureus showed that mutations in these genes resulted in hemin sensitivity, that expression of these genes is hemin activated, and that hemin activation is mediated by the HssRS system (
40,
48). The
hrtAB genes in
C. diphtheriae appear to have a function similar to those reported in
S. aureus and
B. anthracis, which is the detoxification of high levels of hemin. Pfam analysis (
14) of the
C. diphtheriae HrtB permease indicates that it shares similarity with a family of proteins involved in the export of compounds through the cytoplasmic membrane, suggesting that the heme-sensitive phenotype observed in an
hrtAB mutant is associated with a defect in the ability to export excess hemin or compounds produced in response to hemin exposure. Recent studies with
S. aureus using mass spectrometry-based tracking did not confirm a function for HrtAB in heme secretion, suggesting that hemin metabolites or other toxic compounds may be the substrate for the HrtAB system in that species (
40).
It was recently reported that proteins orthologous to HrtAB were present in various bacterial species within the phylum
Firmicutes, including important human pathogens within the genera
Bacillus,
Staphylococcus, and
Listeria (
40,
42). To determine the prevalence of the HrtAB genes in other bacterial phyla, we performed a BLAST search using the
C. diphtheriae HrtB sequence to identify orthologous proteins in the 1,200 completed bacterial genomes available in the NCBI database (
http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi). The results identified two predominant phyla that contained organisms encoding orthologs of HrtB: the above-mentioned
Firmicutes and also the
Actinobacteria, which include genera related to
Corynebacterium,
Streptomyces,
Arthrobacter, and
Mycobacterium; however, no HrtB orthologs were identified in any
Mycobacterium species. No organisms outside these two groups of Gram-positive bacteria and no Gram-negative bacteria encoded proteins with significant sequence similarity to HrtB. In addition to the HrtAB system, other factors are known to protect bacteria from hemin toxicity, including the unusual HbpS protein in
Streptomyces reticuli, which has been proposed to degrade hemin at the cell surface (
25). Various systems in Gram-negative bacteria have also been identified, including ShuS and HemS in
Shigella dysenteriae and
Yersinia enterocolitica, respectively (
44,
51). The mechanisms of protection conferred by these proteins have not been determined, although it is proposed that these intracellular proteins bind hemin and function as either hemin storage or shuttle proteins.
We previously reported that
C. diphtheriae strains with mutations in the
chrSA genes are more sensitive to hemin than the wild-type strain (
4), and it was further noted that this enhanced sensitivity was not associated with decreased expression of HmuO, an enzyme involved in heme degradation and previously shown to be activated by the ChrAS two-component system (
4,
33). It was presumed that the increase in heme sensitivity in a ChrAS mutant was due to reduced expression of an as yet identified gene(s) whose transcription is elevated by the ChrAS regulatory proteins. In this study, we provide strong evidence that the increased hemin sensitivity observed in
chrSA mutants is due to reduced expression of the ChrAS-regulated
hrtAB genes. The hemin sensitivity in the
chrSA mutant C7chrSAΔ was alleviated in the presence of plasmid pMnt-hrtAB, which contains the cloned
hrtAB genes under transcriptional control of the
mntA promoter, a promoter that is independent of ChrAS regulation (
34).
The heme-activated hrtB promoter is the third promoter identified that is regulated by the ChrAS system and the only promoter in the ChrA regulon that is not also affected by the response regulator HrrA. Sequence analysis of the three promoter regions regulated by ChrA, which include hmuO, hrtB, and hemA, revealed the presence of the 10-bp sequence 5′-GGTTGATGTG-3′, which may serve as a possible binding site for ChrA. The hrtB promoter contained two copies of this sequence (9/10 match with consensus), which form a potential stem-loop structure located upstream of the putative −10 element. No sequences matching a strong −35 element were identified at an appropriate distance from the putative −10 region within the hrtB promoter, which is consistent with the requirement for an activator involved in the expression of these genes. Two copies of 5′-GGTTGATGTG-3′ separated by 40 bp are present upstream of the −10 element for the hmuO promoter, and a single copy that matches 8 of 10 residues for this sequence overlaps putative −10 sequences for the hemA promoter (Fig. ). While additional studies are needed to confirm that these regions are important recognition sequences for the ChrA response regulator, the different relative locations and arrangements of these sequences suggest differences in the ChrA binding configurations at these various promoters. It is possible that the interaction of DtxR and HrrA influences ChrA binding at the hmuO promoter in a manner that is not observed with ChrA binding at the hrtB promoter, where HrrA and DtxR do not appear to have any direct role in regulation.
In
C. diphtheriae, it has been well established that DtxR functions in an iron-dependent manner to repress expression of
tox and numerous other genes involved in iron uptake and metabolism (
6,
18,
37). While DtxR functions as an iron-dependent repressor at the ChrAS-regulated
hmuO promoter, this regulatory protein appears to function as an activator at the
hrtB promoter. It was observed that expression of the
hrtB promoter is reduced in a
dtxR mutant, and it was further noted that the presence of the iron chelator EDDA resulted in a 40% decrease in expression of
hrtB in the wild-type strain. Since hemoglobin or hemin is required to activate expression of
hrtB, the presence of the chelator resulted in only a modest reduction in biologically relevant iron levels, as measured by expression of the
tox gene, so the difference between expression under high iron levels and that under very low levels is not possible to determine. Nevertheless, these findings suggest that DtxR functions as an activator at
hrtB and that optimal expression occurs under iron-replete conditions. Analysis of the region upstream of the
hrtB gene failed to identify sequences with significant similarity to the consensus DtxR binding site, which suggests that DtxR may affect expression of the
hrtB promoter through indirect mechanisms. DtxR has not been shown to function as an activator of gene expression in
C. diphtheriae. However, orthologs of DtxR in
Mycobacterium tuberculosis (
16) and in
Corynebacterium glutamicum (
10) are reported to function as both repressors and activators. IdeR, the DtxR ortholog in
M. tuberculosis, activates transcription by directly binding to regions upstream of regulated promoters (
16).
A comparison of
C. diphtheriae ChrAS with
S. aureus and
B. anthracis HssRS suggests that these signal transduction systems have similar roles in the regulation of gene expression through a heme-responsive mechanism. However, several notable differences exist between these systems. The HssRS systems have been shown to regulate only the
hrtAB promoter, while ChrAS controls the expression of at least three promoters, all of which are associated with various aspects of heme metabolism. Although the response regulators ChrA and HrrR exhibit some sequence homology, the similarity is primarily in regions that are commonly conserved in numerous other response regulators within this group of related regulatory proteins (
27). Surprisingly, the cognate sensor kinases for these systems, ChrS and HssS, share no significant sequence similarities (data not shown) (
40). The N-terminal sensor domains of these proteins, which are thought to be critical in the detection of the environmental signal and in anchoring the proteins to the membrane, are remarkably different not only in sequence but also in their predicted structures. We show in this study that ChrS contains 6 transmembrane helices in its N-terminal domain, joined by short loop regions, whereas the sequence of HssS is predicted to contain only two transmembrane domains and one large extracellular loop region. A recent analysis of point mutations in conserved residues in the
B. anthracis HssS N-terminal region identified mutants that had reduced activity, suggesting that this region is important in signal transduction and in responding to hemin exposure; however, in an expanded analysis of all HssS orthologs, no conserved residues that are known to coordinate with the axial iron atom of heme were identified (
40). We have also identified conserved residues in the ChrS N-terminal region that are important for activity; the most notable finding from this analysis is that a mutation in a highly conserved tyrosine (Y61) results in virtually complete loss of ChrS function. Tyrosine residues are known to be important in the coordination of heme in numerous proteins (
28). While it is possible that the Y61 residue may be critical in recognition of hemin or a hemin metabolite, additional studies will be needed to confirm the function of this specific residue in signal transduction.
A recent report described the expression and purification of the ChrS protein in
E. coli and showed that autophosphorylation of ChrS was enhanced in the presence of hemin (
17). Purified ChrS that was incorporated into proteoliposomes gave an absorbance peak of 405 nm in the presence of hemin, suggesting that ChrS directly binds hemin, although the specific nature of the binding and location of the binding site were not determined. It was also noted that the proteoliposomes in the absence of ChrS also bound hemin and gave significant background absorbance in these studies. Numerous attempts in our laboratory to overexpress and purify ChrS have not been successful, even when using techniques very similar to those previously reported (
17). Even moderate expression of ChrS appears to be detrimental to
E. coli strains used in expression studies, presumably due to the presence of the multiple membrane-spanning regions. Small amounts of ChrS that were expressed in our studies could not be purified as glutathione
S-transferase (GST) fusions, presumably due to unusual structural conformations. These fusion proteins also failed to bind to hemin agarose, a technique we previously employed to demonstrate hemin binding to the HmuT protein (
13; M. P. Schmitt, unpublished results).
In this study, we show that transcriptional activation of the
hrtB promoter is mediated by the ChrAS signal transduction system in response to hemin. As depicted schematically in Fig. , it is postulated that hemin or heme-associated factors interact with ChrS, resulting in autophosphorylation at H215, which is followed by the transphosphorylation of ChrA. Phosphorylated ChrA is presumed to undergo a conformational change allowing it to interact with sequences upstream of the
hrtB promoter, resulting in activation of transcription. The products of
hrtAB are predicted to function as an efflux pump to remove excess levels of hemin or factors produced in response to hemin exposure. If hemin directly interacts with ChrS, as proposed in a recent study (
17), then amino acid residues that we have identified that are critical for activity may be associated with hemin binding. Interestingly, 3 of the 5 residues that reduce heme-responsive ChrS function, including the highly conserved Y61, are clustered in a loop region that is predicted to be intracellular, suggesting that the sensing of the signal may occur in the cytosol. Membrane-anchored histidine kinases that detect cytosolic signals are unusual but have been previously described (
22). Confirmation that ChrS detects a signal in the cytosol at its N terminus will require additional studies, since other resides that are important for function, such as the conserved R34, are predicted to be outside the membrane. A sensor that is responsive to intracellular heme levels would be consistent with the proposed function of the various ChrAS-regulated systems, which either interact directly with intracellular heme (HmuO and HrtAB) or are involved in the maintenance of heme homeostasis (HemA and associated heme biosynthetic enzymes).